Research progress of viral pneumonia complicated with invasive pulmonary aspergillosis

doi:10.3877/cma.j.issn.2096-1537.2023.04.008

Abstract

Abstract:

The endemic or global pandemic of viral pneumonia brings severe challenges to human health. Increasing studies in recent years have found that patients with viral pneumonia are susceptible to secondary invasive pulmonary aspergillosis. The latter's emergence will significantly increase the risk of poor prognosis and even death. Seriously, it will threaten patients' lives and bring new challenges to clinical diagnosis and treatment. We discusse the epidemiology, pathogenesis, diagnosis, treatment and prevention of viral pneumonia with invasive pulmonary aspergillosis in this review.

Key words: Viral pneumonia, Invasive pulmonary aspergillosis, Epidemiology, Prophylaxis

Jibin Gong, Guangfeng Liu, Bao Liu, Meichen Yan, Mingmin Pang, Yue Xu, Tingyu Meng, Nana Xu, Shaohua Fan, Hao Wang. Research progress of viral pneumonia complicated with invasive pulmonary aspergillosis[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(04): 385-390.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://icu.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2096-1537.2023.04.008

https://icu.cma-cmc.com.cn/EN/Y2023/V09/I04/385

References 48

1	Alimi Y, Lim WS, Lansbury L, et al. Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe [J]. J Clin Virol, 2017, 95(1): 26-35.
2	World Health Organization. World Health Organization (WHO) (2022) Coronavirus disease (COVID-19) weekly epidemiological update and weekly operational update [EB/OL]. URL
3	Brown GD, Denning DW, Gow NA, et al. Hidden killers: human fungal infections [J]. Sci Transl Med, 2012, 4(165): 165rv13.
4	Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients with severe influenza in the intensive care unit: a retrospective cohort study [J]. Lancet Respir Med, 2018, 6(10): 782-792.
5	Waldeck F, Boroli F, Suh N, et al. Influenza-associated aspergillosis in critically ill patients-a retrospective bi-center cohort study [J]. Eur J Clin Microbiol Infect Dis, 2020, 39(10): 1915-1923.
6	Vanderbek L, Spritt I, Brennet C, et al. Invasive pulmonary aspergillosis complicated by severe influenza [J]. Infect the disease, 2018, 31: 471-480.
7	Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al. A critical influenza care unit for critically ill patients with invasive aspergillosis: a retrospective cohort study [J]. Lancet Resp Med, 2018, 6: 782-792.
8	Schwartz IS, Friedman DZP, Zapernick L, et al. The high incidence of influenza-related invasive pulmonary aspergillosis may not be common: a retrospective cohort study from Alberta, Canada [J]. Clin Infect Dis, 2020, 71: 1760-1763.
9	Chong WH, Neu KP. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review [J]. J Hosp Infect, 2021 , 113: 115-129.
10	Koehler P, Bassetti M, Chakrabarti A, et al; European Confederation of Medical Mycology; International Society for Human Animal Mycology; Asia Fungal Working Group; INFOCUS LATAM/ISHAM Working Group; ISHAM Pan Africa Mycology Working Group; European Society for Clinical Microbiology; Infectious Diseases Fungal Infection Study Group; ESCMID Study Group for Infections in Critically Ill Patients; Interregional Association of Clinical Microbiology and Antimicrobial Chemotherapy; Medical Mycology Society of Nigeria; Medical Mycology Society of China Medicine Education Association; Infectious Diseases Working Party of the German Society for Haematology and Medical Oncology; Association of Medical Microbiology; Infectious Disease Canada.. Definition and treatment of COVID-19-associated pulmonary Aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance [J]. Lancet Infect Dis, 2021, 21(6): e149-e162.
11	Feys S, Gonçalves SM, Khan M, et al. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study [J]. Lancet Respir Med, 2022, 10(12): 1147-1159.
12	Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza:a retrospective cohort study [J]. Lancet Respir Med, 2018, 6: 782-792.
13	Herold S, Becker C, Ridge KM, et al. Influenza virus-induced lung injury: pathogenesis and therapeutic implications [J]. Eur Respir J, 2015, 45(5): 1463-1478.
14	Paul C, Subarao K. Influenza [J]. Lancet, 2017, 390(10095): 697-708.
15	Dewi IM, Janssen NA, Rosati D, et al. Invasive pulmonary aspergillosis associated with viral pneumonitis [J]. Curr Opin Microbiol, 2021, 62: 21-27.
16	Subbarao K, Mahanty S. Respiratory virus infections: understanding COVID-19 [J]. Immunity, 2020, 52(6): 905-909.
17	Espinosa V, Dutta O, McElrath C, et al. Type Ⅲ interferon is a critical regulator of innate antifungal immunity [J]. Sci Immunol, 2017, 2(16): eaan5357.
18	Dutta O, Espinosa V, Wang K, et al. Dectin-1 promotes type Ⅰ and Ⅲ interferon expression to support optimal antifungal immunity in the lung [J]. Front Cell Infect Microbiol, 2020, 10: 321.
19	Kamphuis E, Junt T, Waibler Z, et al. Type Ⅰ interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia [J]. Blood, 2006, 108(10): 3253-3261.
20	Rich HE, McCourt CC, Zheng WQ, et al. Interferon lambda inhibits bacterial uptake during influenza superinfection [J]. Infect Immun, 2019, 87(5): e00114-e00119.
21	Planet PJ, Parker D, Cohen TS, et al. Lambda interferon restructures the nasal microbiome and increases susceptibility to Staphylococcus aureus superinfection [J]. mBio, 2016, 7(1): e01939-e02015.
22	Ghoneim HE, Thomas PG, McCullers JA. Alveolar macrophage depletion promotes bacterial overinfection during influenza infection [J]. Immune, 2013, 191: 1250-1259.
23	Halstead ES, Chroneos ZC. Deadly flu infections: are macrophages to blame? [J]. Expert Rev Anti Infect Ther, 2015, 13: 1425-1428.
24	Tobin JM, Nickridge KL, Ramanan K, et al. Influenza inhibits neutrophil recruitment to the lungs and exacerbates secondary invasive pulmonary aspergillosis [J]. J Immunol, 2020, 205(2): 480-488.
25	Salazar F, Brown GD. Antifungal innate immunity: perspectives from the past 10 years [J]. J Innate Immun, 2018, 10(5-6): 373-397.
26	Stacey, Schultz-Cherry. The role of NK cells in influenza infection [J]. Microbial Immune, 2015, 386: 109-120.
27	Kramer F, Smith GJD, RamFuchil, et al. Influenza [J]. Nat Rev Dis Primers, 2018, 28, 4(1): 3.
28	Kudva A, Scheller EV, Robinson KM, et al. Influenza A inhibits Th17 mediated host defense against bacterial pneumonia in mice [J]. J Immunol, 2011, 186(3): 1666-1674.
29	吕雪莲, 刘泽虎, 刘维达. 院内侵袭性曲霉病的环境因素研究进展 [J]. 国际皮肤性病学杂志, 2007, 33(4): 253-255.
30	Verweij PE, Brüggemann RJM, Azoulay E, et al. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis [J]. Intensive Care Med, 2021, 47(8): 819-834.
31	De Pauw B, Walsh TJ, Donnelly JP, et al; EORTC/MSG Consensus Group. Revised definitions of invasive fungal disease from the EORTC/MSG Consensus Group [J]. Clin Infect Dis, 2008, 46(12): 1813-1821.
32	司淑怡. 侵袭性肺曲霉病的诊断进展 [J]. 中国临床医生杂志, 2016, 44(7): 20-23.
33	任增华, 徐玲. 侵袭性肺曲霉病诊断方法的研究进展 [J]. 中医临床医学, 2018, 25(6): 1009-1015.
34	Xu XY, Sun HM, Zhao BL, et al. Bud tree sign in diagnosis of airway invasive pulmonary Aspergillosis in patients with normal immune function: case report and literature review [J]. Mycol Med, 2013, 23(1): 64-69.
35	许娜娜, 周敏, 尹梅, 等. 高通量测序技术在脓毒症病原微生物检测中的价值 [J/OL]. 中华重症医学电子杂志, 2019, 5(2): 10-13.
36	Yin M, Zheng Y, Zhang L, et al. The real-life performance of metagenomic next-generation sequencing in sepsis [J]. J Infect , 2022, 84(3): 418-467.
37	Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study [J]. Lancet, 2020, 395(10223): 507-513.
38	Nam H, Ison MG. Aspergillosis complicating severe respiratory syncytial virus (RSV) in ICU patients: a retrospective cohort study [J]. Open Forum Infect Dis, 2020, 7(Suppl. 1): S750.
39	Herbrecht R, Patterson TF, Slavin MA, et al. Application of the 2008 definitions for invasive fungal diseases to the trial compar-ing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group MSG 05and the European Organization for Research and Treatment of Cancer Infectious Diseases Group [J]. Clin Infect Dis, 2015, 60(5): 713-720.
40	Bartoletti M, Pascale R, Cricca M, et al; PREDICO Study Group. Epidemiology of invasive pulmonary aspergillosis among intubated patients with COVID-19: a prospective study [J]. Clin Infect Dis, 2021, 73(11): e3606-e3614.
41	Lexander BDA, Perfect JR. Antifungal resistance trends towards the year 2000 [J]. Drugs, 1997, 54(5): 657-678.
42	Wang J, Yang Q, Zhang P, et al. Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series [J]. Crit Care, 2020, 24(1): 299.
43	Patterson TF, Thompson GR, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update from the American Infectious Disease Society [J]. Clin Infect Dis, 2016, 63(4): e1-e60.
44	Ullman AJ, Lipton JH, Viso DH, et al. Posaconazole or fluconazole is used to prevent severe graft host disease [J]. N Engl J Med, 2007, 56(4): 335-47.
45	Cornely OA, Maertens J, Winston DJ, et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia [J]. N Engl J Med, 2007, 356(4): 348-359.
46	Sam QH, Yew WS, Seneviratne CJ, et al. Immunomodulation as therapy for fungal infection: are we closer? [J]. Front Microbiol, 2018, 9: 1612.
47	Costantini C, van de Veerdonk FL, Romani L. COVID-19-associated pulmonary aspergillosis: the other side of the coin [J]. Vaccines (Basel), 2020, 8(4): 713.
48	Xi XH, Lu SH, Mu YP. Severe novel influenza A (H1N1) in Shanghai: clinical features, therapeutic management and risk factors for mortality [J]. Infect Int, 2012, 1: 97-102.

[1]	Hongsheng Cai, Binghui Li, Qian Shen, Wenbo Yang, Yanwen Chen, Gongchi Li. Epidemiological investigation and analysis of inpatients with chronic refractory wounds in a wound repair center in Hubei province [J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2022, 17(04): 283-291.
[2]	Committee of Health Management for Organ Transplant Recipient, China Organ Transplantation Development Foundation. Expert guidance on prophylaxis strategies and health management of organ transplant recipients infected with COVID-19 in China (first edition) [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(01): 1-12.
[3]	Yongbing Qian, Hualian Hang, Haomin Zhang, Yuxiao Deng, Xiaosong Chen, Qiang Xia. Fatal disseminated aspergillosis infection after liver transplantation for acute-on-chronic liver failure: case report [J]. Chinese Journal of Transplantation(Electronic Edition), 2022, 16(05): 306-308.
[4]	Yong Chen, Jianwei Ren, Guangfa Zhu, Yulei Liu, Shaoqin Wu. Clinical features and management of non-transplant patients with invasive pulmonary aspergillosis: analysis of 32 cases [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2023, 16(06): 809-813.
[5]	Yang Li, Yabo Shi, Jianhua Tu. Risk factors and prophylaxis for pancreatic fistula after pancreaticoduodenectomy [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(03): 352-355.
[6]	Haisen Zhang, Jinbao Ye, Pengfei Gao. Epidemiological investigation of polypoid lesions of gallbladder and influence factors of disease progression [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(01): 91-95.
[7]	Zhihui Tang, Wei Huang, Fei Luo, Wenhao Wang. Analysis of epidemiological characteristics and mortality factors of patients with spontaneous intracerebral hemorrhage [J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2022, 08(04): 224-228.
[8]	Fengxin Li, Jianwen Xv, Ruyu Chen, Changqiu Li, Jiling Wang, Xiuwei Tan, Haifeng Bu, Hailin Wang, Yiji Su. Epidemiological Characteristics of Spinal Cord Injury in the Elderly on The First Affiliated Hospital of Guangxi Medical University from 2015 to 2020 [J]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2023, 09(01): 45-50.
[9]	Yifan Wang, Yan Chen, Jinmin Peng, Bin Du, Li Weng. Epidemiology of sepsis in China [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(01): 89-94.
[10]	Da Li, Daya Zhang, Runxiang Chen, Xiaodong Zhang, Shimei Huang, Chen Chen, fan Zeng, Shiju Chen, Feihu Bai. Epidemiological characteristics and risk factors of Helicobacter pylori infection in Dongfang city of Hainan province [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(08): 858-864.
[11]	Min Huang, Xuefen Chen, Zhouru Shen, Zhiyi He, Jing Bai, Meihua Li, Meiling Yang, Jingmin Deng. Clinical characteristics of 21 cases of mixed types of pulmonary aspergillosis [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(12): 1217-1223.
[12]	Ke Han, Xiangyao Wang, Nan Ru, Xiaotong Niu, Jingyuan Xiang, Yan Wang, Fei Gao, Ningli Chai, Enqiang Linghu. The prevalence of chronic diarrhea in obese adults: a systematic review with meta-analysis [J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2023, 10(02): 115-120.
[13]	Shenxin Chen, Yaqi Zhai, Baoguo Bu, Dexin Chen, Lang Wu, Kaixuan Fang, Wenjing Liu, Mingyang Li, Enqiang Linghu. Analysis of clinical features of autoimmune pancreatitis [J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2023, 10(01): 46-51.
[14]	Nan Zhang, Xueli Sheng, Jun Shao, Shiyuan Fang, Fang Wang, Xian Zhu, Binjie Zhou. Out-of-hospital cardiac arrest patients with prehospital recovery of spontaneous circulation: an epidemiological study [J]. Chinese Journal of Hygiene Rescue(Electronic Edition), 2022, 08(06): 326-330.
[15]	Anle Li, Shuai Zhu, Zhihao Hu, Xuejin Xu, Qian Peng, Ying Ji, Yiying Zhang, Fang Xiang. The epidemiological trend and characteristics of stroke in elderly patients with hypertension [J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2022, 16(04): 247-252.

Please choose a citation manager

Content to export